Nutrien (NYSE:NTR - Get Free Report) posted its quarterly earnings results on Wednesday. The company reported $2.61 EPS for the quarter, missing the consensus estimate of $2.70 by ($0.09), Briefing.com reports. Nutrien had a net margin of 8.58% and a return on equity of 8.84%. The business had revenue of $10.81 billion during the quarter, compared to analyst estimates of $10.44 billion. During the same period last year, the firm posted $2.65 earnings per share. The company's quarterly revenue was up 3.6% on a year-over-year basis.
Nutrien Price Performance
Shares of NTR traded down $0.16 during midday trading on Thursday, reaching $66.76. The stock had a trading volume of 3,009,547 shares, compared to its average volume of 3,190,199. Nutrien has a 52 week low of $53.03 and a 52 week high of $85.36. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.24 and a quick ratio of 0.59. The firm's 50 day moving average price is $66.21 and its 200-day moving average price is $70.47. The company has a market capitalization of $31.93 billion, a P/E ratio of 13.60, a P/E/G ratio of 0.67 and a beta of 0.61.
Nutrien Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, October 16th. Stockholders of record on Tuesday, September 29th will be given a dividend of $0.55 per share. The ex-dividend date is Tuesday, September 29th. This represents a $2.20 annualized dividend and a dividend yield of 3.3%. Nutrien's dividend payout ratio (DPR) is 44.81%.
Nutrien News Roundup
Here are the key news stories impacting Nutrien this week:
- Positive Sentiment: Nutrien’s board declared a quarterly dividend of US$0.55 per share, payable October 16 to shareholders of record September 29. The payment supports the stock’s income appeal and represents an annualized yield of approximately 3.3%. Nutrien Declares Quarterly Dividend of US$0.55 per Share
- Positive Sentiment: Second-quarter revenue reached approximately $10.81 billion, up 3.6% year over year and above the $10.44 billion consensus estimate. The company also generated strong operating cash flow and continued investing in its operations, indicating resilience in its core fertilizer businesses. Nutrien Releases Q2 2026 Earnings
- Neutral Sentiment: Analyst price targets remain above the current trading level in many cases, with a reported six-month median target of $82. However, the range is wide, including a $65 target, reflecting differing views on fertilizer pricing and Nutrien’s earnings outlook. Nutrien Price Targets and Institutional Activity
- Negative Sentiment: Nutrien reported quarterly EPS of $2.61, below the $2.70 consensus estimate and down from $2.65 a year earlier. The earnings miss is likely outweighing the revenue beat, particularly as lower sales and higher costs pressured profitability. Nutrien Q2 Earnings Miss Estimates
Analyst Ratings Changes
A number of brokerages recently commented on NTR. Bank of America upgraded Nutrien from a "neutral" rating to a "buy" rating and set a $82.00 price objective for the company in a research note on Thursday, April 30th. UBS Group lowered their price target on shares of Nutrien from $67.00 to $65.00 and set a "sell" rating for the company in a research report on Monday, May 11th. JPMorgan Chase & Co. increased their price objective on shares of Nutrien from $78.00 to $80.00 and gave the stock an "overweight" rating in a report on Monday, May 11th. TD Securities reissued a "buy" rating on shares of Nutrien in a research note on Wednesday, May 6th. Finally, Weiss Ratings upgraded shares of Nutrien from a "hold (c)" rating to a "hold (c+)" rating in a research note on Monday, June 1st. Sixteen investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $81.84.
Check Out Our Latest Analysis on Nutrien
Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of the stock. Sfam LLC acquired a new position in shares of Nutrien in the 4th quarter worth $37,000. Geneos Wealth Management Inc. raised its holdings in shares of Nutrien by 42.4% during the second quarter. Geneos Wealth Management Inc. now owns 735 shares of the company's stock valued at $43,000 after acquiring an additional 219 shares during the period. Fulcrum Asset Management LLP acquired a new position in Nutrien in the 3rd quarter worth approximately $46,000. Acadian Asset Management LLC acquired a new position in Nutrien in the 1st quarter worth approximately $54,000. Finally, Arax Advisory Partners grew its position in Nutrien by 23.5% during the 4th quarter. Arax Advisory Partners now owns 1,525 shares of the company's stock worth $94,000 after purchasing an additional 290 shares in the last quarter. Institutional investors own 63.10% of the company's stock.
About Nutrien
(
Get Free Report)
Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien's business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.
Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Nutrien, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.
While Nutrien currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.